Opinion|Videos|September 16, 2024
Challenges in Managing Co-Morbid CRM Conditions
Key Takeaways
- Polypharmacy and drug-drug interactions complicate the management of co-morbid CRM conditions, necessitating careful medication review and adjustment.
- Overlapping symptoms of CRM conditions require a multidisciplinary approach for accurate diagnosis and effective management.
A panel of medical experts examines the challenges in managing co-morbid cardiometabolic conditions, emphasizing the most prevalent complications associated with this disease state.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are the major clinical challenges in managing patients with co-morbid CRM conditions?
This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Diagnosing Alzheimer's Disease Agitation: Triggers, Care Specialties, and the Role of Primary Care
2
Defining Alzheimer's Disease Agitation: Diagnostic Criteria, Symptoms, and Disease Course
3
FDA Approves First Autoinjector for At-Home IV-Equivalent Diuresis
4
Nipocalimab Improves gMG Outcomes Across East Asian Subgroup
5